Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors

Brain Research

Volumn 777, Issue 1-2, 1997, Pages 110-118

  Seaton, Tracey A ^a   Cooper, J Mark ^a   Schapira, Anthony H V ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Complex I inhibitor; Free radical; Mitochondria; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; FREE RADICAL; ISOQUINOLINE; OXOGLUTARATE DEHYDROGENASE; ROTENONE; SCAVENGER; TETRAHYDROISOQUINOLINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0031589740     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01034-2     Document Type: Article

References (70)

1. + neurotoxicity, Neurosci. Lett. 193 (1995) 53-56.
2. [2] A.J. Anderson, J.H. Su, C.W. Cotman, DNA damage and apoptosis in Alzheimer's disease: co-localisation with c-Jun immunoreactivity, relationship to brain area, and postmortem delay, J. Neurosci. 16 (1996) 1710-1719.
3. [3] K. Banki, E. Hutter, E. Colombo, N.J. Gonchoroff, A. Perl, Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression, J. Biol. Chem. 271 (1996) 32994-33001.
4. [4] J.P. Beaver, P. Waring, A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes, Eur. J. Cell Biol. 68 (1995) 47-54.
5. [5] A. Boveris, Mitochondrial production of superoxide radical and hydrogen peroxide, Adv. Exp. Biol. Med. 78 (1977) 67-82.
6. [6] D.E. Bredesen, Neural apoptosis, Ann. Neurol. 38 (1995) 839-851.
7. [7] J. Bustamante, A.F.G. Slater, S. Orrenius, Antioxidant inhibition of thymocyte apoptosis by dihydrolipoic acid, Free Rad. Biol. Med. 19 (1995) 339-347.
8. [8] T.M. Buttke, P.A. Sandstrom, Oxidative stress as a mediator of apoptosis, Immunol. Today 15 (1994) 7-10.
9. [9] M. Cino, R.F. Del Maestro, Generation of hydrogen peroxide by brain mitochondria: the effect of reoxygenation following postdecapitative ischemia, Arch. Biochem. Biophys. 269 (1989) 623-638.
10. [10] M.J. Cleeter, J.M. Cooper, A.H.V. Schapira, Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement, J. Neurochem. 58 (1992) 786-789.
11. [11] A. Cossarizza, C. Franceschi, D. Monti, S. Savioli, E. Bellesia, R. Rivabene, L. Biondo, G. Rainaldo, A. Tinari, W. Malorni, Protective effect of N-acetylcysteine in tumour necrosis factor α-induced apoptosis in U9837 cells: the role of mitochondria, Exp. Cell Res. 220 (1995) 232-240.
12. [12] B. Dipasquale, A.M. Marini, R.J. Youle, Apoptosis and DNA degradation induced by 1-methyl-4-phenypyridinium in neurons, Biochem. Biophys. Res. Commun. 181 (1991) 1442-1448.
13. [13] P. Doherty, D.A. Mann, F.S. Walsh, Comparison of the effects of NGF, activators of protein kinase C and a calcium ionophore on the expression of Thy-1 and N-CAM in PC12 cell cultures, J. Cell. Biol. 107 (1988) 333-340.
14. [14] M. Dragunow, R.L.M. Faull, P. Lawlor, E.J. Beilharz, K. Singleton, E.B. Walker, E. Mee, In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, Neuroreport 6 (1995) 1053-1057.
15. [15] V. Goossens, J. Grooten, K. De Vos, W. Fiers, Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity, Proc. Natl. Acad. Sci. USA 92 (1995) 8115-8119.
16. [16] L.N. Grinberg, A. Samuni, Nitroxide stable radical prevents primaquine-induced lysis of red blood cells, Biochim. Biophys. Acta 1201 (1994) 284-288.
17. [17] D. Han, H.J. Tritschler, L. Packer, α-Lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line, Biochem. Biophys. Res. Commun. 207 (1995) 258-264.
18. [18] A. Hartley, J.M. Stone, C. Heron, J.M. Cooper, A.H.V. Schapira, Complex I inhibitors induce dose dependent apoptosis in PC12 cells: relevance to Parkinson's disease, J. Neurochem. 63 (1994) 1987-1990.
19. +) induces NADH dependent superoxide formation, and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles, Biochem. Biophys. Res. Commun. 170 (1990) 1049-1055.
20. [20] R.E. Heikkila, G. Cohen, 6-Hydroxydopamine: evidence for superoxide radicals as an oxidative intermediate, Science 181 (1973) 456-457.
21. [21] I. Irwin, J.W. Langston, MPTP and Parkinson's disease, in: A.L. Harvey (Ed.), Natural and Synthetic Neurotoxins, Academic Press, New York, 1993, pp. 225-256.
22. [22] V. Jackson-Lewis, M. Jakowec, R.E. Burke, S. Przedborski, Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurodegeneration 4 (1995) 257-269.
23. [23] M. Jacobson, M.C. Raff, Programmed cell death and Bcl-2 protection in very low oxygen, Nature 374 (1995) 814-816.
24. + by dopamine neurones explains selective toxicity, Proc. Natl. Acad. Sci. USA 82 (1985) 2173-2177.
25. [25] B.S. Jeon, V. Jackson-Lewis, R.E. Burke, 6-Hydroxydopamine lesions of the rat substantia nigra: time course and morphology of cell death, Neurodegeneration 4 (1995) 131-137.
26. [26] P. Jenner, A.H.V. Schapira, C.D. Marsden, New insights into the cause of Parkinson's disease, Neurology 42 (1992) 2241-2250.
27. [27] D.J. Kane, T.A. Sarafian, R. Anton, E.B. Hahn, E.B. Gralla, J.S. Valentine, T. Örd, D.E. Bredesen, Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species, Science 262 (1993) 1274-1277.
28. [28] J.F.H. Kerr, A.H. Wylie, A.R. Currie, Apoptosis: a basic phenomenon with wide ranging implications in tissue kinetics, Br. J. Cancer 26 (1972) 239-257.
29. [29] M. Lam, G. Dubyak, L. Chen, G. Nunez, R.L. Miesfeld, C.W. Distelhorst, Evidence that Bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated calcium fluxes, Proc. Natl. Acad. Sci. USA 91 (1994) 6569-6573.
30. [30] J.W. Langston, P. Ballard, J.W. Tetrud, I. Irwin, Chronic parkinsonism in humans due to a product of meperidine analog synthesis, Science 219 (1983) 979-980.
31. [31] W. Malorni, R. Rivabene, P. Matarrese, The antioxidant N-acetylcysteine protects cultured epithelial cells from menadione-induced cytopathology, Chem. Biol. Interact. 96 (1995) 113-123.
32. [32] W. Maruyama, D. Nakahara, M. Ota, T. Takahashi, A. Takehashi, T. Nagatsu, M. Naoi, N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study, J. Neurochem. 59 (1992) 395-400.
33. [33] W. Maruyama, W. Dosert, M. Naoi, Dopamine-derived 1-methyl-6,7-dihydroxyisoquinoline as hydroxyl promotors and scavengers: in vivo and in vitro studies, J. Neurochem. 64 (1995) 2635-2643.
34. [34] W. Maruyama, W. Dosert, K. Matsubara, M. Naoi, N-Methy(R)salsolinol produces hydroxyl radicals: Involvement to neurotoxicity, Free Rad. Biol. Med. 19 (1995) 67-75.
35. [35] K.St.P. McNaught, U. Thull, P.A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, C.D. Marsden, Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Biochem. Pharmacol. 50 (1995) 1903-1911.
36. [36] K.St.P. McNaught, C. Altomare, S. Cellamare, A. Carotti, U. Thull, P.A. Carrupt, B. Testa, P. Jenner, C.D. Marsden, Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Neuroreport 6 (1995) 1105-1108.
37. [37] K.St.P. McNaught, U. Thull, P.A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, C.D. Marsden, Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurodegeneration 5 (1996) 265-274.
38. [38] K.St.P. McNaught, U. Thull, P.A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, C.D. Marsden, Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration, Biochem. Pharmacol. 51 (1996) 1503-1511.
39. [39] K.St.P. McNaught, U. Thull, P.A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, C.D. Marsden, Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurosci. Lett. 206 (1996) 37-40.
40. [40] Y. Mizuno, S. Matuda, H. Yoshino, H. Moro, N. Hattori, S. Ikebe, An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease, Ann. Neurol. 35 (1994) 201-210.
41. +) in a ventral mesencephalic-striatal coculture in rat, Neurosci. Lett. 170 (1994) 191-194.
42. [42] H. Mochizuki, K. Goto, H. Mori, Y. Mizuno, Histochemical detection of apoptosis in Parkinson's disease, J. Neurol. Sci. 137 (1996) 120-123.
43. [43] T. Nagatsu, M. Yoshida, An endogenous substance of the brain tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions, Neurosci. Lett. 87 (1988) 178-182.
44. [44] M. Naoi, W. Maruyama, P. Dosert, Y. Hashizume, D. Nakahara, T. Takahashi, M. Ohta, Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioural studies, Brain Res. 709 (1986) 285-295.
45. [45] M. Naoi, W. Maruyama, J.H. Zhang, T. Takahashi, Y. Deng, P. Dosert, Enzymatic oxidation of the dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into 1,2(N)-dimethyl-6,7-dihydoxyisoquinolinium ion, Life Sci. 57 (1995) 1061-1066.
46. [46] Y. Nishimura, H. Akiyama, S. Yonehara, H. Kondo, K. Ikeda, M. Kato, E. Iseki, K. Kosaka, Fas antigen expression in brains of patients with Alzheimer's disease, Brain Res. 695 (1995) 137-145.
47. [47] T. Niwa, N. Takeda, N. Kandea, Y. Hashizume, T. Nagatsu, Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroisoquinoline in parkinsonian and normal human brains, Biochem. Biophys. Res. Commun. 144 (1987) 1084-1089.
48. [48] D. Offen, I. Ziv, H. Sternin, E. Melamed, A. Hochman, Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease, Exp. Neurol. 141 (1996) 32-39.
49. +) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation, Biochem. Pharmacol. 51 (1996) 267-273.
50. [50] C. Pifl, B. Giros, M.G. Caron, Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-phenylpyridinium, J. Neurosci. 13 (1993) 4246-4253.
51. [51] J.H.M. Prehn, J. Jordan, G.D. Ghadge, E. Preis, M.F. Galindo, R.P. Roos, J. Krieglstein, R.J. Miller, Calcium and reactive oxygen species in staurosporine-induced neuronal apoptosis, J. Neurochem. 68 (1997) 1679-1685.
52. [52] R.R. Ratan, T.H. Murphy, J.M. Baraban, Oxidative stress induces apoptosis in embryonic cortical neurons, J. Neurochem. 62 (1994) 376-379.
53. [53] S.P. Sanders, J.L. Zweier, P. Kuppusamy, S.J. Harrison, D.J. Bassett, E.W. Gabrielson, J.T. Sylvester, Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport, J. Clin. Invest. 91 (1993) 46-52.
54. [54] T. Satoh, B.J. Cummings, C.W. Cotman, Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity, Brain Res. 697 (1995) 35-43.
55. [55] A.H. Schapira V, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, C.D. Marsden, Mitochondrial Complex I deficiency in Parkinson's disease, Lancet i (1989) 1269.
56. [56] A.H.V. Schapira, J.M. Cooper, D. Dexter, J.B. Clark, P. Jenner, C.D. Marsden, Mitochondrial complex I deficiency in Parkinson's disease, J. Neurochem. 54 (1990) 823-827.
57. [57] J.B. Schulz, D.R. Henshaw, D. Siwek, B.G. Jenkins, R.J. Ferrante, P.B. Cipolloni, N.W. Kowall, B.R. Rosen, M.F. Beal, Involvement of free radicals in excitotoxicity in vivo, J. Neurochem. 64 (1995) 2239-2247.
58. [58] A.F. Slater, C.S. Nobel, E. Maellaro, J. Bustamente, M. Kimland, S. Orrenius, Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis, Biochem. J. 306 (1995) 771-778.
59. [59] K. Suzuki, Y. Mizuno, Y. Yamauchi, T. Natgatsu, M. Yoshida, Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain, J. Neurol. Sci. 109 (1992) 219-223.
60. [60] J.L. Tilly, K.I. Tilly, Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles, Endocrinology 136 (1995) 242-252.
61. [61] K.F. Tipton, T.P. Singer, Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds, J. Neurochem. 61 (1995) 1191-1206.
62. [62] J. Torres-Roca, H. Lecoeur, C. Amatore, M.L. Gougeon, The early intracellular production of a reactive oxygen intermediate mediates apoptosis in dexamethasone-treated lymphocytes, Cell Death Differ. 2 (1995) 309-319.
63. [63] C.M. Troy, M.L. Shelanski, Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells, Proc. Natl. Acad. Sci. USA 91 (1994) 6384-6387.
64. [64] G. Walkinshaw, C.M. Waters, Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis, Neuroscience 63 (1994) 975-987.
65. [65] R.J.A. Wanders, J.P.N. Ruiter, F.A. Wijburg, Studies on mitochondrial oxidative phosphorylation in permeabilised human skin fibroblasts: application to mitochondrial encephalomyopathies, Biochem. Biophys. Acta 1181 (1993) 219-222.
66. [66] J.T. Wolfe, D. Ross, G.M. Cohen, A role for metals and free radicals in the induction of apoptosis in thymocytes, FEBS Letts. 352 (1994) 58-62.
67. [67] E.J. Wolvetang, K.L. Johnson, K. Krauer, S. Ralph, A.W. Linnane, Mitochondrial respiratory chain inhibitors induced apoptosis, FEBS Lett. 339 (1994) 40-44.
68. [68] J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, W. Wang, Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science 275 (1997) 1129-1132.
69. [69] N. Zamzami, P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S.A. Susin, P.X. Petit, B. Mignotte, G. Kroemer, Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death, J. Exp. Med. 182 (1995) 367-377.
70. [70] I. Ziv, E. Melamed, N. Nardi, D. Lurie, A. Achiron, D. Offen, A. Barzilai, Dopamine induced apoptosis-like cell death in culture chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease, Neurosci. Lett. 170 (1994) 136-140.